Skip to main content
OpenTrials
Completed

NCT Number: NCT05225064

Increasing COVID-19 Vaccine Uptake in Developing Countries (Bihar)

Working with governments in Bihar, India, we will evaluate a number of mechanisms to increase vaccine uptake. These include household vaccination visits instead of community vaccination clinic.monetary and non-monetary incentives, and concurrent mask promotion. This ClinicalTrials entry contains results only for the study in Bihar.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Vaccination Refusal Behavior COVID-19 Coronaviridae Infections Coronavirus Infections Health Behavior Infections Lung Diseases Nidovirales Infections Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Treatment Adherence and Compliance Treatment Refusal Virus Diseases

Age range

15 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Project Concern International

Patna, Bihar, 800001, India

About this study

The goal of the study is to identify strategies that best promote and support COVID vaccine uptake in developing countries, we propose to test a range of scalable social and behavioural interventions. This could help policy makers design and employ interventions that are effective. This is especially valuable in resource constrained contexts where funds and institutional resources can be diverted towards interventions that have proven to work.

In Bihar the intervention will be village-level social mobilization involving community promotion, including in-person vaccine reinforcement, and household-level social mobilization. Some treatment villages will receive household- level interventions with varying intensity (different proportion of households will be visited). There will also an accompanying mask distribution campaign during household visits where the importance of mask-wearing as a complement to vaccine use will be explained.

This ClinicalTrials entry contains results only for the study in Bihar.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Lives in study village

Exclusion criteria

  • Does not live in study village

Treatment and study plan

Incentives to be vaccinated

Behavioral

Individuals will be provided with a guaranteed cash payment, entry into a cash lottery, or guaranteed gift of food if they are vaccinated

Mask

Device

Individuals are given cloth masks

Encouragement to wear a mask

Behavioral

Individuals who are not wearing masks over their mouth and nose are stopped in public places and encouraged to wear a mask

Vaccination made more convenient

Behavioral

Vaccines are conducted at the household-level rather than the village-level

Social mobilization campaign to be vaccinated

Behavioral

Village-level social mobilization campaign to be vaccinated

Primary outcomes

  1. Percent of individuals who receive the first, second, or third dose of covid vaccine

    Time frame: up to 4 weeks (endline may vary depending on estimated uptake rates)

    Prevalence of vaccination with difference doses

Sponsors and collaborators

Lead sponsor

Yale University

Other

Collaborators

  • Innovations for Poverty Action
  • Lahore University of Management Sciences
  • University of California, Berkeley
  • University of Connecticut

Registry information

Important dates

Study start
2022
Primary completion
2022
Study completion
2022
First posted
Feb 4, 2022
Registry last updated
Jun 22, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.